BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9494536)

  • 1. Chelating effect of human serum proteins on metal-catalyzed ascorbate radical generation.
    Satoh K; Ida Y; Kimura S; Taguchi K; Numaguchi M; Gomi K; Kochi M; Sakagami H
    Anticancer Res; 1997; 17(6D):4377-80. PubMed ID: 9494536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metals and their antagonists on the radical intensity and cytotoxicity of ascorbates.
    Satoh K; Ida Y; Kochi M; Tajima M; Kashimata M; Sakagami H
    Anticancer Res; 1997; 17(5A):3355-60. PubMed ID: 9413172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between sodium 5,6-benzylidene-L-ascorbate and dopamine.
    Satoh K; Ida Y; Kochi M; Sakagami H
    Anticancer Res; 1998; 18(5A):3565-9. PubMed ID: 9858940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of physiological fluids on radical intensity of sodium ascorbate and sodium 5,6-benzylidene-L-ascorbate.
    Satoh K; Ida Y; Asano K; Hisamitsu T; Inagaki M; Sho S; Kochi M; Tanaka T; Sakagami H
    Anticancer Res; 1997; 17(6D):4457-61. PubMed ID: 9494550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating factors of radical intensity and cytotoxic activity of ascorbate (review).
    Sakagami H; Satoh K
    Anticancer Res; 1997; 17(5A):3513-20. PubMed ID: 9413196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
    Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
    Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
    Sakagami H; Satoh K; Kochi M
    Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between sodium 5,6-benzylidene-L-ascorbate and gallic acid.
    Koyama N; Satoh K; Ida Y; Hiroi M; Oi T; Kochi M; Yamamoto Y; Sakagami H
    Anticancer Res; 1999; 19(2A):1159-64. PubMed ID: 10368669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cysteine, N-acetyl-L-cysteine and glutathione on cytotoxic activity of antioxidants.
    Satoh K; Sakagami H
    Anticancer Res; 1997; 17(3C):2175-9. PubMed ID: 9216683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of sodium 5,6-benzylidene-L-ascorbate.
    Sakagami H; Yamamura TS; Takahashi H; Shibuya I; Takeda M
    Anticancer Res; 1995; 15(4):1269-74. PubMed ID: 7654007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cobalt ion on radical intensity and cytotoxic activity of antioxidants.
    Sakagami T; Satoh K; Ishihara M; Sakagami H; Takeda F; Kochi M; Takeda M
    Anticancer Res; 2000; 20(5A):3143-50. PubMed ID: 11062735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper, but not iron, enhances apoptosis-inducing activity of antioxidants.
    Satoh K; Kadofuku T; Sakagami H
    Anticancer Res; 1997; 17(4A):2487-90. PubMed ID: 9252668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electron spin resonance (ESR) study on the mechanism of ascorbyl radical production by metal-binding proteins.
    Mouithys-Mickalad A; Deby C; Deby-Dupont G; Lamy M
    Biometals; 1998 Apr; 11(2):81-8. PubMed ID: 9542060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific action of sodium 5,6-benzylidene-L-ascorbate in N-nitrosodiethylamine-administered mouse model.
    Asano K; Satoh K; Kochi M; Kusama K; Sakagami H
    Anticancer Res; 2001; 21(1A):281-4. PubMed ID: 11299747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hydrogen peroxide in cytotoxicity induction by ascorbates and other redox compounds.
    Iwasaka K; Koyama N; Nogaki A; Maruyama S; Tamura A; Takano H; Takahama M; Kochi M; Satoh K; Sakagami H
    Anticancer Res; 1998; 18(6A):4333-7. PubMed ID: 9891488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate.
    Asano K; Satoh K; Hosaka M; Arakawa H; Inagaki M; Hisamitsu T; Maeda M; Kochi M; Sakagami H
    Anticancer Res; 1999; 19(1A):229-36. PubMed ID: 10226547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of ascorbate solution by chelating agents that block redox cycling of metal ions.
    Nishikimi M; Ozawa T
    Biochem Int; 1987 Jan; 14(1):111-7. PubMed ID: 3566770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hydrogen peroxide in antitumor activity induction by sodium 5,6-benzylidene-L-ascorbate.
    Sakagami H; Hosaka M; Arakawa H; Maeda M; Satoh K; Ida Y; Asano K; Hisamitsu T; Takimoto M; Ota H; Inagaki M; Sasuga K; Sho S; Tanaka T; Utsumi N; Oi T; Kochi M
    Anticancer Res; 1998; 18(4A):2519-24. PubMed ID: 9703903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the type of serum in the medium on sodium ascorbate-induced cytotoxicity.
    Sakagami H; Satoh K; Sugaya K; Iida M; Hirota N; Matsumoto K; Kimura S; Gomi K; Taguchi S; Kato S; Takeda M
    Anticancer Res; 1996; 16(4A):1937-41. PubMed ID: 8712724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metal ions on radical intensity and cytotoxic activity of ascorbate.
    Satoh K; Sakagami H
    Anticancer Res; 1997; 17(2A):1125-9. PubMed ID: 9137459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.